Latest Non-steroidal anti-inflammatory drugs Stories
- Initial Hepatoren® Phase II study results NASHVILLE, Tenn., March 3, 2015 /PRNewswire/ -- Cumberland Pharmaceuticals Inc.
NEWARK, Calif., March 3, 2015 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the 27(th) Annual Roth Conference in Laguna Niguel, California.
NEWARK, Calif., Feb. 12, 2015 /PRNewswire/ -- Depomed, Inc.
CAMBIA® (Diclofenac Potassium for Oral Solution) is elevated to Level A, based on rigorous clinical data demonstrating its effectiveness for acute migraine attacks, consistent with other therapies
Reading medication labels will help prevent serious health problems BETHESDA, Md., Feb.
NEWARK, Calif., Feb. 4, 2015 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at two healthcare conferences in February.
- - Shortened infusion time offers convenient administration NASHVILLE, Tenn., Feb.
EUGENE, Ore., Feb.
Xarelto Drug Safety Label Warns Bleeding Is A Common Adverse Reaction Of The Blood Thinner And Xarelto Bleeding Side-Effects Lawsuits Claim The Anticoagulant Does Not Have An Antidote Should Severe
A daily regimen of low-dose aspirin may not actually help you prevent a heart attack or stroke – in fact, it might actually do more harm than good, according to a new study.
More Images (1 images) »